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Abstract
It has been widely reported that quorum-sensing incapable strains of Pseudomonas aeruginosa are less virulent than wild
type strains. However, quorum sensing mutants of P. aeruginosa have been shown to develop other spontaneous mutations
under prolonged culture conditions, and one of the phenotypes of P. aeruginosa that is frequently affected by this
phenomenon is type IV pili-dependent motility, referred to as twitching motility. As twitching motility has been reported to
be important for adhesion and colonisation, we aimed to generate a quorum-sensing knockout for which the heritage was
recorded and the virulence factor production in areas unrelated to quorum sensing was known to be intact. We created a
lasIRrhlIR quadruple knockout in PAO1 using a published technique that allows for the deletion of antibiotic resistance
cartridges following mutagenesis, to create an unmarked QS knockout of PAO1, thereby avoiding the need for use of
antibiotics in culturing, which can have subtle effects on bacterial phenotype. We phenotyped this mutant demonstrating
that it produced reduced levels of protease and elastase, barely detectable levels of pyoverdin and undetectable levels of
the quorum sensing signal molecules N-3-oxododecanoly-L-homoserine lactone and N-butyryl homoserine lactone, but
retained full twitching motility. We then used a mouse model of acute lung infection with P. aeruginosa to demonstrate that
the lasIRrhlIR knockout strain showed equal persistence to wild type parental PAO1, induced equal or greater neutrophil
infiltration to the lungs, and induced similar levels of expression of inflammatory cytokines in the lungs and similar antibody
responses, both in terms of magnitude and isotype. Our results suggest, in contrast to previous reports, that lack of quorum
sensing alone does not significantly affect the immunogenicity, infectiveness and persistence of P. aeruginosa in a mouse
model of acute lung infection.
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Introduction
The role of quorum sensing (QS) and biofilm formation in
Pseudomonas aeruginosa biology is clear, and previous reports have
suggested that knocking out QS systems in P. aeruginosa results in
decreased virulence in animal models of infection [1,2,3,4,5] and
has impacts on bacterial growth rate in culture. The deletion of
both the synthase genes and the responder genes for both 3-oxo-
N-dodecanoyl-L-homoserine lactone (3OC12HSL) and the other
principal homoserine lactone QS signal produced by P. aeruginosa,
N-butyryl-L-homoserine lactone (C4HSL) should result in a
quadruple knockout that will not respond to or produce
3OC12HSL or C4HSL. Previously reported lasI/rhlI knockouts
including PAO1-JP2 have been reported to be less virulent than
wild type P. aeruginosa PAO1 in a range of animal models
[3,4,5,6,7,8,9,10,11]. However, QS mutants of P. aeruginosa have
been shown to develop spontaneous mutations under prolonged
culture conditions [12,13], and one of the phenotypes of P.
aeruginosa that is frequently affected by this phenomenon is type IV
pili-dependent motility, referred to as twitching motility [12]. In
fact, twitching motility was originally reported to be controlled by
QS [14] but was later confirmed to be independently regulated
[15]. Interestingly, JP-2 has been reported to be incapable of
twitching motility [14] which suggests that this strain is likely to
contain secondary mutations in a gene (or genes) required for
twitching motility. It has been shown that, unlike the PAO1
parental strain, a PAO1 mutant with defective pili is unable to
bind to respiratory epithelial cells and cannot induce production of
the proinflammatory and neutrophil-recruiting chemokine inter-
leukin (IL)-8 [16]. It has also been reported in many studies that
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type-IV pili are integral for adherence to and colonization of
mucosal surfaces (reviewed in Hahn et al. [17]). It is therefore
important that twitching motility remains intact in any QS
knockout P. aeruginosa used for in vivo infection studies assessing the
role of QS in bacterial infectivity and persistence.
Because of the inherent and spontaneous mutations that occur
during standard laboratory subculturing of P. aeruginosa, we created
a lasIRrhlIR knockout in a strain for which the heritage was
recorded and the virulence factor production in areas unrelated to
QS was known to be intact. We used a technique described by
Hoang et al. [18], which allows for the deletion of antibiotic
resistance cartridges following mutagenesis, to create an unmarked
QS knockout of PAO1. Such a knockout strain has two benefits:
firstly an unmarked knockout can be further genetically modified
without the need for multiple resistance cassettes and secondly, it
has been found that subinhibitory concentrations of antibiotics can
profoundly influence the phenotype of P. aeruginosa [19,20,21]. A
knockout strain that does not require antibiotic selection for
maintenance of mutation would allow the comparison of QS
knockout strains to isogenic wild-type bacteria without any
possibility of phenotypic changes being generated in the bacteria
because of the presence of antibiotics in the culture medium.
After creation of the quadruple lasIRrhlIR knockout, we tested it
in a mouse model of P. aeruginosa lung infection to compare the
course of infection with that of the parental PAO1. We found that
the knockout showed equal persistence, induced comparable or
greater inflammation, and resulted in identical antibody responses
in terms of magnitude and immunoglobulin isotype to parental
PAO1.
Materials and Methods
Bacterial Strains, Plasmids and Media
The wild type P. aeruginosa used as the basis for this study was
PAO1 strain ATCC 15692. E. coli strain DH5a was used in all
genetic manipulations and in the preparation of DNA sequencing
templates, and E. coli S17-1 was used as the donor strain in
bacterial conjugation for allelic exchange mutagenesis. All
bacterial strains used in this study are listed in Table 1.
P. aeruginosa and E. coli were cultured in LB-Lennox broth (LB)
or cation-adjusted Mueller Hinton broth (CAMHB) or on LB
solidified with 1.5% agar (LBA). Antibiotic concentrations used for
selection of E. coli were 100 mg/mL ampicillin, 12.5 mg/mL
tetracycline, and 50 mg/mL kanamycin and for P. aeruginosa were
250 mg/mL carbenicillin, and 200 mg/mL tetracycline.
Construction of PAO1DlasIR, PAO1DrhlIR, and
PAO1DlasIRrhlIR
Unmarked deletion mutants of PAO1 were constructed using
the Flp-FRT recombination system for site specific excision of
chromosomal sequences described [18]. Briefly, 1 kb sections that
flanked the lasIR and rhlIR region(s) to be deleted from PAO1
chromosomal DNA were PCR amplified and cloned into
pGEMTeasy and sequenced to ensure that no mutations in these
flanking regions had been introduced by PCR. The upstream and
downstream flanking regions of the las or rhl regions were ligated
and then cloned into pOK12 (creating pJL005 and pJL006
respectively) and the FRT/TetR cassette from pCBW108 cloned
into the internal SacI site resulting in pOK12 constructs pJL007
and pJL008 containing the flanking regions of lasIR or rhlIR
regions separated by the FRT::TetR cassette. The resultant clones
were then digested with SpeI and cloned into the suicide vector
pRIC380. This vector carries the genes sacBR, which promote
sensitivity to sucrose, and oriT which enables conjugal transfer.
The resultant clones were transformed into the E. coli donor strain
S17-1 in preparation for mating with P. aeruginosa PAO1.
Following conjugation, the transconjugants were plated onto
LBA without sodium chloride and supplemented with 5% sucrose
and containing tetracycline to select for colonies in which the
plasmid had excised while leaving the homologously recombined
lasIR::TetR or rhlIR::TetR alleles in the chromosome. The TetR
gene was then excised using the pFLP2 plasmid that expresses the
Flp recombinase as described previously [18] creating P. aeruginosa
strains with the lasIR or rhlIR regions deleted and replaced with an
FRT sequence. Allelic exchange deletion mutants were confirmed
by both PCR and Southern hybridization of isolated chromosomal
DNA. A list of all plasmids used in this study is given in Table 1
and all primers used are listed in Table 2.
Assays of Bacterial Phenotypes
Growth curves. P. aeruginosa strains were cultured overnight
in CAMHB at 37uC shaking at 250 r.p.m. Quadruplicate 200 mL
aliquots of 1:100 dilutions of overnight cultures were added to
wells of a sterile 96 well plate (BD Biosciences, Mountainview,
CA), which was then incubated for 10 h at 37uC shaking in a BIO-
TEKH SynergyTM HT microplate luminometer (BIO-TEK,
Winooski, VT, USA). Optical density readings (605 nm) were
taken every 20 min and subtracted from the blank (CAMHB
only).
Extraction of acylated homoserine lactones (AHLs) from
culture supernatant and AHL bioluminescence assay. The
supernatant of 8 h cultures of P. aeruginosa strains cultured in LB at
37uC shaking at 250 r.p.m. was collected by centrifuging the
culture at 30006 g for 10 min. The supernatant was sterilised
though a 0.22 mm filter and AHLs extracted using a method
adapted from that described by Rice et al. [22]. Equal volumes of
culture supernatant and 0.01% glacial acetic acid in ethyl acetate
were mixed, centrifuged at 100006 g for 2 min and the organic
layer containing the AHL retained. This was repeated at least
three times and the collected organic phase dried overnight at
room temperature. The sediment was resuspended in 50 mL of
ethyl acetate.
3OC12HSL and C4HSL were quantified using biolumines-
cence reporter strains as described previously [23,24]. Briefly,
20 mL of culture supernatant or AHL standards were added to the
wells of a white opaque microtiter plate (PerkinElmer, Wellesley,
MA, USA), and 180 mL of mid-log phase cultures of E. coli
containing pSB1073 or pSB406 was added to the microtiter plate,
gently agitated and incubated at room temperature for 1 h, after
which the luminescence was measured using a Veritas Microplate
Luminometer (Veritas, Sunnyvale, CA) or a BIO-TEKH Syner-
gyTM HT microplate luminometer (BIO-TEK). The concentra-
tion of AHL in culture supernatants was determined using
dilutions of synthetic AHL as a standard curve. The results were
standardized to the expression from a vehicle control (the limit of
detection for the assay), and because the interassay variation was
large, the results are presented as a percentage of the wild-type.
Twitching motility assay. Twitching motility was assayed
using the subsurface stab assay described previously [25]. Briefly,
the P. aeruginosa strain to be tested was stab inoculated through a
plate of LB solidified with 1% agar to the underlying Petri dish and
incubated at 37uC with saturated humidity. After 20 h at 37uC the
diameter of the interstitial biofilm was measured.
Rhamnolipid synthesis assay. Triplicate 5 mL aliquots of
overnight culture were applied to a dry rhamnolipid assay agar
(prepared as described by Kohler et al. [26]) and allowed to dry.
The plate was incubated at 37uC for 18 h then chilled overnight at
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Table 1. Bacterial strains and plasmids used in this study.
Bacterial strains Relevant characteristic(s) Source or reference
E. coli
DH5a recA endA1 gyrA96 hsdR17 thi-1 supE44 relA1 Q80 dlacZDM15 Invitrogen
S17-1 thi pro hsdR recA chr::RP4-2 [44]
P. aeruginosa
PAO1 Wild type P. aeruginosa strain ATCC 15692 American Type Culture
Collection
PAO1DlasIR PAO1 with deletion of lasIR region This study
PAO1DrhlIR PAO1 with deletion of rhlIR region This study
PAO1DlasIRrhlIR PAO1DrhlIR with deletion of lasIR region This study
Plasmids
pPS854 FRT cassette vector [18]
EZ-TN5,TET-1. Source of TetR gene Epicenter
pGEM-T E. coli cloning vector; ApR Promega
pOK12 E. coli cloning vector; KmR [45]
pRIC380 P. aeruginosa suicide vector; ApR [46]
pFLP2 [18]
pSB406 C4HSL biosensor plasmid [23]
pSB1073 3OC12HSL biosensor plasmid [24]
pCBW108 pPS854 containing 1.4 Kb TetR gene amplified from EZ-TN5,TET-1. cloned into EcoRI site.
Source of FRT/TetR cassette
[47] This study
pJL001 1 Kb lasR upstream region amplified from PAO1 genome in pGEMTeasy; ApR This study
pJL002 1 Kb lasI downstream region amplified from PAO1 genome in pGEMTeasy; ApR This study
pJL003 1 Kb rhlR upstream region amplified from PAO1 genome in pGEMTeasy; ApR This study
pJL004 1 Kb rhlI downstream region amplified from PAO1 genome in pGEMTeasy; ApR This study
pJL005 pOK12 containing lasR upstream region and lasI downstream region ligated at SacI sites
and cloned into XhoI and NdeI sites of pOK12; KmR
This study
pJL006 pOK12 containing rhlR upstream region and rhlI downstream region ligated at SacI sites
and cloned into KpnI and NdeI sites of pOK12; KmR
This study
pJL007 pJL005 containing 1.4 KB FRT/TetR cassette from pCBW108 cloned into SacI site; KmR, TcR This study
pJL008 pJL006 containing 1.4 KB FRT/TetR cassette from pCBW108 cloned into SacI site; KmR, TcR This study
pJL009 3.4 Kb SpeI insert from pJL008 cloned into pRIC380; ApR, TcR This study
pJL010 3.4 Kb SpeI insert from pJL009 cloned into pRIC380; ApR, TcR This study
doi:10.1371/journal.pone.0060973.t001
Table 2. Primers used in this study.
Oligonucleotide Sequence 59239 Description
TetR Forward GCGGAATTCACCTGAAGTCAGCCCCATACG EcoRI site inserted at 59 end (italics)
TetR Reverse CGCGAATTCCTGCCAAGGGTTGGTTTGC EcoRI site inserted at 59 end (italics)
lasR Upstream Flanking Region Forward CTCGAGGCGTAGCGATGGGCAACAAG XhoI site inserted at 59 end (italics).
lasR Upstream Flanking Region Reverse GAGCTCCGTAGTCCTGGCTGTCCTTAGGC SacI site inserted at 59 end (italics).
lasI Downstream Flanking Region Forward GAGCTCAACAGCGACTGGCGGTTTC SacI site inserted at the 59 end (italics)
lasI Downstream Flanking Region Reverse CATATGGCCTGAACGACCTGAACGG NdeI site inserted at the 59 end (italics).
rhlR upstream Flanking Region Forward GGTACCGCACGCATCGCTCACGAG KpnI site inserted at the 59 end (italics)
rhlR Upstream Flanking Region Reverse GAGCTCCGTCCCACCACAGCAAAAAG SacI site inserted at the 59 end (italics)
rhlI Downstream Flanking Region Forward GAGCTCGCCGCAGAAGGTCAAGGG SacI site inserted at the 59 end (italics)
rhlI Downstream Flanking Region Reverse CATATGCCTCGCCGCCCCTGTATTAC NdeI site inserted at the 59 end (italics)
doi:10.1371/journal.pone.0060973.t002
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4uC. The plates were then examined for the presence or absence
of a zone of clearance.
Skim milk protease assay. This method was adapted from
that described by Sokol et al. [27]. In brief, three 10 mL droplets of
overnight broth culture were applied to a dry skim milk agar plate
and grown for 18 h at 37uC. The zone of clearance was measured
with the diameter of the colony subtracted.
Elastase assay. The determination of elastolytic activity of
16 h P. aeruginosa cultures was performed using a protocol based on
those described by Ohman et al. [28] and Rust et al. [29]. In brief,
P. aeruginosa strains were cultured in CAMHB and then centrifuged
at 30006 g for 10 min. The supernatant was then filter sterilized
using a 0.22 mm syringe filter and either used immediately or
stored at 4uC for up to 24 h. In triplicate, 10 mg of elastin Congo
red (ECR), 500 mL of ECR buffer (0.1 M TrisCl and 10 mM
CaCl2) and either 500 mL of the sterile spent supernatants or
500 mL of a CAMHB negative control were added to 5 mL
polystyrene tubes (BD FalconH, BD Biosciences) and incubated at
37uC for 6 h with 250 r.p.m. shaking. The incubation was stopped
by the addition of 100 mL of 0.12 M Na2EDTA and the remaining
solids were pelleted by centrifugation at 30006 g for 10 min. The
soluble Congo red in the aqueous supernatant was quantitated
using duplicates of each supernatant in a 96-well microtiter plate
(BD Biosciences) with the CAMHB negative control as a blank
and measuring the absorbance at 495 nm in a Biomek spectro-
photometer (Beckman Coulter, La Brea, CA, USA).
Pyocyanin extraction and assay. The pyocyanin produc-
tion from 16 h cultures of P. aeruginosa was determined by first
extracting the pyocyanin from the culture supernatant as described
by Hassett et al. [30]. To assay pyocyanin, duplicate 100 mL
aliquots of the HCl extraction were added to microtiter wells and
the absorbance at 520 nm was measured in a Biomek spectro-
photometer (Beckman Coulter).
Mouse Lung Infection Models
Ethics statement. All mouse studies were conducted in
accord with the Australian Code of Practice for the Care and Use
of Animals for Scientific Purposes, and were approved by the
Animal Experimentation and Ethics committees of CQUniversity
(approval No. A09/02-242) and University of New South Wales
(approval Nos. 04/105A and 03/10). Animals were anesthetized
for infection as described below, and were euthanized for tissue
collection. All experiments were designed to use the minimum
number of animals consistent with statistical validity, and all
animals were monitored daily and euthanized if signs of distress
were detected.
Acute infection model. For studies of acute infection and
inflammation, groups of five male BALB/c mice 8–12 weeks old
(ARC, Perth, WA, Australia) were inoculated intratracheally at
day 0 with 16106 colony forming units CFU) of PAO1 or
PAO1DlasIRrhlIR in 20 mL PBS containing 0.03% ethanol. A
group of mice were also sham treated (anesthetized and cannula
inserted, but no treatment given). Mice were sedated with a tail
vein injection of Alfaxan at 12 mg/kg body weight (90 mg
alphaxalone, 30 mg alphadolone acetate; Schering-Plough Animal
Health, Baulkham Hills, NSW, Australia), and treatment admin-
istered by means of a 20 G paediatric cannula (Terumo Medical,
Macquarie Park, NSW, Australia) inserted in the trachea. Mice
from all treatment groups were then sacrificed at 4 h, 24 h or 10
days after infection, and lung tissue and BAL collected for analysis.
For analysis of antibody responses, groups of five mice were given
16103 CFU of PAO1 or PAO1DlasIRrhlIR in a 0.5% agar slurry
administered intratracheally by the method described above.
These mice were bled by cardiac puncture under terminal
anesthesia at day 21. Blood was collected in a 1.1 mL Z-gel tube
(Sarstedt, Mawson Lakes, SA, Australia) that was then left at room
temperature for at least 30 min before centrifuging at 20006 g for
10 min. The serum was collected and kept frozen at 220uC until
use for evaluation of anti-Pseudomonas serum antibody concen-
trations.
Bronchoalveolar lavage (BAL). To obtain BAL, 0.5 mL of
sterile PBS was slowly flushed into the lungs of euthanized mice,
and as much as possible of the PBS was recovered. Differential cell
counts were performed on cytospin preparations of the BAL fixed
with DPX mountant (Scharlau, Barcelona, Spain) and stained
using the Diff-Quik Staining Kit 64851 (a modified version of the
Wright’s stain; Veterinary Medical Surgical Supply, Maryville,
NSW, Australia) according to the manufacturer’s instructions.
Bacterial enumeration in the lung tissue and BAL. A
section of the mouse lung was homogenized in 2 mL sterile PBS
using a tissue homogenizer. The bacterial CFU in the BAL fluid
and homogenized lung were determined by making serial dilutions
and plating onto LBA.
Preparation of cDNA from mouse lung tissue. Total
RNA was extracted from the lung tissue using TRIzolH Reagent
(Invitrogen, Mulgrave, VIC, Australia) with a maximum of
100 mg of tissue per mL of TRIzolH Reagent. Tissue was
removed from RNAlaterH storage solution and homogenized by
bead dissociation in TRIzolH using 2.4 mm zirconia/silica beads
(Daintree Scientific, St Helens, TAS, Australia). Beads and cellular
debris were pelleted by centrifugation at 10 0006 g for 10 min at
4uC. Approximately 1 mL of supernatant was removed to a fresh
tube and total RNA extracted as per the TRIzolH protocol.
Isolated RNA was resuspended in 50 mL of DEPC-treated water
(Ambion) and DNAse treated using a TURBO DNA-free kitTM
(Ambion) according to the manufacturer’s instructions. The
concentration and purity of recovered RNA was quantified using
a NanoDropTM 1000 spectrophotometer (Thermo Scientific,
Scoresby, VIC, Australia). cDNA was synthesized from 500 ng
of total RNA using the SuperscriptTM III Reverse Transcriptase
kit according to the manufacturer’s instructions.
Quantitative reverse transcription real time PCR (RT-
qPCR) for inflammatory markers in mouse lung. Primer
sequences for reference gene b-actin [31], TNFa, IL1b (both [32])
and IL6 ([33]) have been previously published. Primer sequences
for mouse keratinocyte cytokine (KC) (analogue of human IL-8)
(forward 59–GCTGGGATTCACCTCAAGAA–39, reverse 59–
AGGTGCCATCAGAGCAGTCT–39) were designed from Gen-
Bank sequences using Primer 3-web version 0.3.0 [34]. Primer
pairs were checked for reaction efficiency using triplicate serial
dilutions of template cDNA with efficiency calculated as described
in Pfaffl, 2001 [35]. Quantitative PCR (qPCR) was performed
using the PlatinumHSYBRHGreen qPCR Supermix-UDG (Invi-
trogen). Each qPCR reaction contained 5 mL of cDNA diluted
1:5–1:10 with DEPC-treated H2O, and final primer concentra-
tions of 300 nM. The reactions were performed on a RotorGene
3000H (Corbett Life Science) with an initial incubation of 50uC for
10 min then 95uC for 10 min followed by 40 reaction cycles of
95uC for 15 sec, 60uC for 30 sec, and acquiring fluorescence at
72uC for 20 sec. All products underwent melt curve analysis.
Replicates showing errors were omitted from further analysis. The
average of the technical replicates was used to determine the ratio
of the target to the reference genes (b-actin and GAPDH) and
corrected for the primer efficiency as described by Pfaffl [35].
Interassay variation was calculated by comparing the Ct values of
a standard incorporated into all qPCR reactions. A coefficient of
variation was calculated using PRISMH v.5 software (Graph Pad
A QS Mutant Pseudomonas That Retains Infectivity
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Inc. La Jolla, CA, USA) and values below 10% deemed to be
acceptable.
Detection of anti-P. aeruginosa Antibodies by Enzyme-
linked Immunosorbent Assay (ELISA)
To prepare PAO1 sonicate to use as the capture antigen for the
ELISA, PAO1 bacterial suspension was autoclaved for 15 min at
121uC and 15 kPa. The suspension was sonicated on ice three
times with a Branson SonifierH S250D digital sonicator using a
fine point probe (Branson Ultrasonics Corp., Danbury, CT, USA)
before the cellular debris was pelleted at 4uC and 30006 g for
10 min. The supernatant was then aliquotted and stored at –80uC.
A bicinchoninic acid assay was used to determine the protein
concentration. The concentration of the unknown was calculated
against a BSA standard curve.
Preparation of P. aeruginosa IgG and IgM positive and
negative sera. Heat-killed bacteria were diluted to the equiv-
alent of 26109 CFU/mL and 50 mL (16108 CFU equivalents)
were injected intraperitoneally into male BALB/c mice. Anti-P.
aeruginosa IgM-positive sera was obtained after 8 days, and anti-P.
aeruginosa IgG-positive was obtained after 24 days with repeat
injections on day 8 and day 16. Negative control serum was
collected from unimmunised mice. The positive sera were
arbitrarily defined as containing 16106 U/mL of anti-P. aeruginosa
antibody.
Anti-P. aeruginosa IgG and IgM ELISA. Ninety-six well
Polysorp microtiter plates (Nunc, Rochester, NY, USA) were
coated with 100 mL/well of P. aeruginosa sonicate diluted to 10 mg/
mL in coating buffer (1.59 g/L Na2CO3 and 2.94 g/L NaHCO3
in diH2O pH 9.6). The plates were sealed and incubated
overnight at 4uC. The plates were then washed three times in
Dulbecco’s modified phosphate buffered saline (DPBS) supple-
mented with 0.05% v/v Tween-20 then blocked with reagent
diluent (DPBS with 5% skim milk powder, prepared on the day).
All samples were prepared in reagent diluents and a standard
curve was generated using the positive control serum.
After blocking, the plate was washed three times with washing
buffer and then 100 mL/well of the samples added in duplicate to
the plate, which was sealed and incubated at room temperature for
2 h. Following this incubation, the plate was washed with DPBS-
Tween and 100 mL/well of the diluted detection antibodies added.
The detection antibodies were diluted in reagent diluent to the
following concentrations: biotinylated anti-mouse IgG1 heavy
chain (1 mg/mL); biotinylated anti-mouse IgG2a heavy chain
(1 mg/mL); and biotinylated anti-mouse IgM heavy chain
(0.25 mg/mL) (all AbD Serotec, Oxford, UK) and allowed to
incubate at room temperature for at least 10 min. The plate was
sealed and incubated at room temperature for 2 h.
The plate was washed with DPBS-Tween and 100 mL/well of
0.2 mg/mL Streptavidin-HRP (Amersham Biosciences) diluted in
1% w/v BSA in DPBS was added, the plate sealed and incubated
at room temperature for 1 h. After the incubation, the plate was
washed with DPBS-Tween and 100 mL/well of 3,3,5,59-tetra-
methylbenzidine diluted to 110 mg/mL in citrate acetate (pH 9.6)
supplemented with 0.2% v/v H2O2, and the colour left to develop
for 5 min. The development was stopped by the addition of
100 mL/well of 0.16 M H2SO4. The absorbance was then read at
450 nm with a reference filter of 520 nm on a BioRad microplate
reader and the software package Microplate Manager v 5.2.1 was
used to calculate the standard curve. The least dilute sample with
an absorbance reading that fit on the linear portion of the curve
was used to calculate the antibody concentration of the sample.
Statistical analysis. All statistical analysis was performed
using GraphPad Prism v 5. Distribution of all data was tested for
normality using the Kolmogorov–Smirnov test. Data sets that
were normally distributed are expressed as mean 6 standard
deviation, and differences between groups were evaluated using t-
test or ANOVA. Data sets (antibody titers) that were not normally
distributed are presented as median with individual points.
Differences between groups were evaluated using the Mann–
Whitney U test.
Results
Phenotypic Characterisation of PAO1DlasIR, PAO1DrhlIR
and PAO1DlasIRrhlIR Deletion Mutants
To re-examine the role of quorum sensing in infection, we
generated an unmarked deletion mutant of PAO1 that lacks both
the las and rhl quorum sensing systems. We also further minimized
any chance of other mutations arising by limiting its subculturing
prior to characterization in various phenotypic assays and mouse
models of infection. Because of the hierarchical nature of the las
and rhl quorum sensing systems the PAO1DrhlIR mutant was
created first as a lasIR knockout would also be deficient in many of
the phenotypes that we used to confirm the rhlIR knockout.
An unmarked PAO1DrhlIR deletion mutant was generated and
a number of phenotypic assays were performed to confirm that
this strain displayed phenotypes consistent with previously
published observations for mutants of rhlI and rhlR and to confirm
that it had not acquired secondary mutations that result in
defective twitching motility. As expected, our PAO1DrhlIR mutant
produced reduced levels of elastase (Fig. 1a) and protease (Fig. 1b)
relative to PAO1, did not produce rhamnolipid (Fig. 1e), produced
barely detectable levels of pyocyanin (Fig. 1c), and retained wild-
type twitching motility (Fig. 1d).
After verification of the PAO1DrhlIR mutant phenotypes,
PAO1DlasIR and PAO1DlasIRrhlIR deletion mutants were creat-
ed. These mutants were assayed to verify that they had phenotypes
consistent with published observations and that they had not
acquired secondary mutations that result in defective twitching
motility. PAO1DlasIR showed reduced levels of elastase produc-
tion whereas the PAO1DlasIRrhlIR quadruple knockouts produced
barely detectable levels of elastase (Fig. 1a). Protease production by
PAO1DlasIR was significantly reduced compared with the wild-
type control, and was even lower in the quadruple knockout
PAO1DlasIRrhlIR (Fig. 1b). PAO1DlasIR did not show a significant
defect in pyocyanin production whereas PAO1DlasIRrhlIR pro-
duced barely detectable levels of pyocyanin (Fig. 1c). Importantly,
both PAO1DlasIR and PAO1DlasIRrhlIR retained wild type levels
of twitching motility (Fig. 1d).
All mutants were also tested to determine the levels of
production of C4HSL or 3OC12HSL in the culture supernatant
using bioluminescence reporters specific for C4HSL [23] and
3OC12HSL [24]. The concentration of AHLs produced was
calculated using a standard curve of synthetic AHL, but because
the interassay variation was large, the results are presented as a
percentage of the wild-type (Fig. 2a, b). The rhlIR mutant
produced no detectable C4HSL and higher levels of 3OC12HSL
than wild type PAO1; the lasIR mutant produced similar levels of
C4HSL to wild type and no detectable 3OC12HSL, and the
lasIRrhlIR mutant produced no detectable C4HSL or 3OC12HSL.
Characteristics of Lung Infection in BALB/c Mice
To evaluate the effects of knocking out both lasIR and rhlIR on
the course of an infection, groups of BALB/c mice were infected
with either PAO1 or PAO1DlasIRrhlIR, and followed for 10 days.
Mice were euthanized at 4 h, 24 h and 10 days after infection, and
bacterial numbers, lung levels of inflammatory leukocytes, and
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Figure 1. Phenotypic characteristics of QS mutants. Elastase production (a), protease production (b) pyocyanin production (c) twitching
motility (d) rhamnolipid production (e) of QS mutants compared with parental PAO1. Rhamnolipid production only tested for DrhlIR mutant. All
results represented as means 6 SD of at least triplicate determinations. Differences between groups assessed with unpaired t-test; **P,0.05;
**P,0.01; ***P,0.001.
doi:10.1371/journal.pone.0060973.g001
Figure 2. Production of C4HSL and 3OC12HSL by QS mutants compared with PAO1. The capacity of all mutants to produce C4HSL (a) and
3OC12HSL (b) is presented. Because of interassay variability, all results are presented as percent of production by wild type PAO1. Results for 100 mM
C4HSL (a) or 3OC12HSL (b) included as positive controls. Values represent mean 6 SD of at least triplicate determinations. LB: LB broth (negative
control). ND: not detected.
doi:10.1371/journal.pone.0060973.g002
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lung expression of mRNA for inflammatory cytokines TNFa, IL-
1b and mKC (IL-8 analogue) were evaluated. The bacterial
numbers recovered from lung tissue and BAL at each time point
are shown in Fig. 3, and indicate that at each time point there
were no significant differences between wild type PAO1 and the
PAO1DlasIRrhlIR mutant, although there was a trend to recovery
of higher numbers of PAO1DlasIRrhlIR than PAO1 at 4 h and
24 h. Low levels of infection with both strains were maintained out
to 10 days.
We also investigated leukocyte infiltration into the lung by
examining leukocytes in BAL at all time points (Fig. 4). At 4 h and
24 h, the infiltrate was dominated by neutrophils (80–90%),
whereas at day 10, neutrophils constituted only about 10% of
infiltrating cells, with monocytes and other cells (mostly lympho-
cytes) both representing approximately 45% of cells. The only
significant differences between mice inoculated with PAO1 and
PAO1DlasIRrhlIR were in total white cells and neutrophils at 4 h
and 24 h post infection, where neutrophil numbers (and hence
total white cell counts) were significantly higher in mice infected
with PAO1DlasIRrhlIR (p,0.01, unpaired t test).
We used RT-qPCR to investigate the level of expression of
three cytokines characteristic of acute inflammation, TNFa, IL1b
and mKC, a mouse analogue of human IL-8, at 24 h post
infection. The results, shown in Fig. 5, demonstrate that there was
no significant difference in the level of expression of any of these
cytokines between mice infected with PAO1 and those infected
with PAO1DlasIRrhlIR.
Lastly, in a different set of experiments, mice were infected with
PAO1 or PAO1DlasIRrhlIR embedded in agar slurry, euthanized
at 22 days after initial infection and after a second dose of bacteria
at day 21, and serum levels of P. aeruginosa-specific IgM, IgG1 and
IgG2a measured by ELISA. Figure 6 shows that there was no
significant difference in the titres of any of the isotypes between
mice infected with PAO1 and those infected with PAO1DlasIRrh-
lIR.
Discussion
The literature contains numerous examples of animal models of
P. aeruginosa infection. In many of these, a comparison of a wild
type (usually PAO1) and a variety of QS-deficient strains suggest
that QS-controlled virulence factors are important in the
pathogenesis of infection, and that most QS mutants are less
virulent than wild type P. aeruginosa. It is unquestionable that QS
controlled biofilm formation and virulence factor production plays
an important role in bacterial virulence, particularly in clinical
settings such as cystic fibrosis (CF) (e.g. [7]). However, because
many QS mutants are known to acquire other mutations,
particularly in twitching motility, which could affect infection
and dissemination, we decided to create a rigorously designed
quadruple knockout, and further minimize any chance of other
mutations arising by limiting its culturing. Such a knockout would
allow the separation of effects of bacterial adherence and
infectivity from the effects of QS-controlled virulence.
Creation of the PAO1DlasIRrhlIR was a multi-step process. A
PAO1DrhlIR mutant was created first because of the hierarchical
nature of the las and rhl quorum sensing systems: a lasIR knockout
would be deficient inmany of the phenotypes used to confirm a rhlIR
knockout, making the phenotypic confirmation of a rhlIR knockout
on a PAO1DlasIR backgroundmore difficult. However, creating the
rhlIR knockout first enabled us to confirm that its phenotype was as
expected, with loss of pyocyanin production being the key
phenotype change. The deletion of the lasI and lasR genes also
resulted in the deletion of rsaL, but we predicted that an rsaL deletion
would not affect the mutant significantly because its product is a lasI
repressor, and this was supported by the phenotypic studies on the
PAO1DlasIRrhlIR and PAO1DlasIR mutants generated. The
characteristics of the PAO1DlasIRrhlIR knockouts clearly demon-
strate that they are unable to produce a number of keyQS-regulated
virulence factors, and cannot respond to exogenous AHLs, but that
they retain full twitching capability.
The results of the studies in the mouse model of lung infection
suggest that there is no significant difference between the
persistence of PAO1 and PAO1DlasIRrhlIR in mouse lungs, or in
their ability to induce an inflammatory response in the host,
although there is a suggestion from the neutrophil counts that
PAO1DlasIRrhlIR actually induces a stronger inflammatory
infiltrate than the parental PAO1, and the trend to higher
bacterial numbers recovered in PAO1DlasIRrhlIR infected mice is
consistent with the slightly faster growth rate of this strain (results
not shown). Wu et al. also observed a stronger inflammatory
response to a PAO1 lasIrhlI knockout strain (PAO1-JP2) in a rat
Figure 3. Bacterial recovery from lungs of mice infected with PAO1 or PAO1DlasIRrhlIR. Bronchoalveolar lavage and lung tissue was
collected from groups of five mice at 4 h, 24 h and 10 d after intratracheal infection with 16106 CFU of either PAO1 (hatched bars) or PAO1DlasIRrhlI
(QSneg, open bars). Lung tissue was homogenised, serial dilutions made in PBS and cultured on LBA to estimate bacterial numbers in lung tissue. An
aliquot of BAL fluid was also serially diluted in PBS and dilutions plated on LBA to estimate bacterial numbers in BAL (airways). Results expressed as
mean 6 SD for five mice at each point. There were no significant differences in numbers of PAO1 and PAO1DlasIRrhlIR recovered at any time point.
doi:10.1371/journal.pone.0060973.g003
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model, but unlike in our study, this was accompanied by a more
rapid clearance of bacteria [11]. However, as PAO1-JP2 is known
to be deficient in twitching motility [14], this is likely to affect its
ability to colonise lungs and hence its ability to persist. However,
other studies in rats and mice have also suggested that quorum
sensing-defective mutants are cleared more effectively than wild
type bacteria [11,36]. For example, a study using a neonatal
BALB/c model of infection reported that a PAO1DlasR mutant
was virtually avirulent, causing no mortality, no evidence of lung
pathology and only 15% of mice showed evidence of bacterial
replication in vivo [37], although the authors found that PAO1-
DlasR were still recovered in the lungs 24 h post infection in
numbers similar to PAO1, indicating that although the bacteria
could persist they did not cause pathology [37]. In our study, the
bacterial numbers in PAO1DlasIRrhlIR-infected and wild type
PAO1-infected mice were similar at each time point, with low
numbers persisting out to at least 10 days after infection. Analysis
of the cytokine mRNA in the lungs indicates that there is little
difference in the ability of the two strains to stimulate effective
proinflammatory cytokine responses, although analysis of the
PMN recruitment to the lung indicates that PAO1DlasIRrhlIR is
more effective at stimulating innate immunity.
An explanation for some of the differences between our
results and those of others may be that, although PAO1 is the
laboratory standard for P. aeruginosa, there is a great deal of
genetic diversity between laboratories in the PAO1 strains used
[13]. For example, twitching motility is one of the phenotypes
commonly lost during ongoing laboratory culture, because of
the development of point mutations in other regulators such as
vfr [12]. For example, the PAO1 lasIrhlI knockout strain (PAO1-
JP2) used in many studies has been reported to lack twitching
motility [14] and this can reduce the ability of the bacteria to
colonize mammalian epithelia. Thus, some of the reported
reduced virulence of QS mutant P. aeruginosa may be the
consequence of impaired colonization by twitching-deficient
bacteria. Care was taken in the creation of the PAO1DlasIRrh-
lIR mutant used in this study to ensure that such secondary
mutations had not occurred, increasing confidence that the
results from this study were in fact a reflection of the differences
in quorum sensing ability of PAO1DlasIRrhIR and wild type
PAO1, and not of other mutations in PAO1.
High antibody titres against P. aeruginosa have been associated
with decreases in lung function and poorer outcomes of
infection [38,39]. There were detectable titres of anti-P.
Figure 4. Leukocyte infiltrate in bronchoalveolar lavage (BAL) fluid from lungs of mice infected with PAO1 or PAO1DlasIRrhlIR. BAL
fluid was collected from mice at 4 h, 24 h and 10 d after intratracheal infection with 16106 CFU of either PAO1 (hatched bars) or PAO1DlasIRrhlIR
(QSneg, open bars). An aliquot of fluid from each mouse was centrifuged in a cytospin, and slides stained with DiffQuik for differential counting. A
minimum of 200 cells per slide were counted. Results expressed as mean 6 SD for individual BAL fluids from five mice per group at each time point.
Differences between groups analysed with an unpaired t test. *P,0.05, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0060973.g004
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aeruginosa IgM antibodies at 10 days post lung infection in the
acute infection model, but no detectable IgG1 or IgG2a, and no
difference between PAO1-infected mice and those infected with
PAO1DlasIRrhIR (results not shown). To evaluate later immune
responses, we generated a more chronic infection by giving
mice P. aeruginosa in an agar slurry, which delays bacterial
clearance, and collecting serum at day 22 after an acute
bacterial challenge on day 21. P. aeruginosa-specific IgM, IgG1
and IgG2a were all easily detectable at this time point, but
there was no difference in the titers of any of the isotypes
between PAO1DlasIRrhlIR-infected and PAO1-infected mice.
This is in contrast to a previous report using a rat model of
infection suggesting that the IgG1 response was higher in rats
infected with PAO1 compared with rats infected with a QS
signal-deficient mutant (PAO1DlasIrhlI) [40]. As IgG1 is
associated with prohumoral Th2 type responses in mice, this
implied that QS-deficient mutants generated a more Th2-biased
response, but we saw no such difference. The difference
between our results and those reported by Wu et al. could be
due to species variation, because of the differences in persistence
between PAO1 and PAO1DlasIrhlI observed in Wu et al.’s study,
where the mutant was cleared more effectively than the wild
type, or could be related to differences in the bacterial strains
other than those defined.
The mouse model used in this study was an acute lung infection,
and our results do not exclude the likelihood that QS-mediated
induction of biofilm formation and virulence factor production
play important roles in chronic infections. It would be of interest to
repeat these studies in models of chronic infection, particularly
immune deficiency or cystic fibrosis, which in humans, results in
increased susceptibility to P. aeruginosa infection. It remains entirely
possible that QS mutants may be less virulent in such situations
than wild type P. aeruginosa, for a combination of reasons related to
both defects in biofilm formation and virulence factor production
and to host factors and the characteristics of the inflammatory and
immune responses to infection, which are known to be aberrant in
people with cystic fibrosis (CF) [41]. In this context, although it is
clear that P. aeruginosa exists in biofilms in CF lung [42,43] and the
bacterial populations present in CF lung are heterogeneous and
always include some QS-competent bacteria [42], it is relevant to
note that it has been reported that QS-deficient mutants arise
spontaneously after some years in people with CF with chronic P.
aeruginosa lung infection [7]. The most frequently observed
mutation in the genes of the QS systems is in lasR¸ which could
suggest that while QS systems are important for initiating and
maintaining chronic infection, ‘‘social cheating’’ by subpopulations
of QS-deficient P. aeruginosa could confer a survival advantage in
the environment of the chronically-infected and damaged CF
lung.
In conclusion, our results suggest that careful control of culture
and propagation of QS deficient PAO1 derivatives to prevent
additional mutations and the loss of such important characteristics
as twitching motility may eliminate a significant proportion of the
previously observed differences in infectivity and persistence of
QS-deficient bacteria and wild-type P. aeruginosa in animal models,
and allow a more precise evaluation of the importance of QS and
QS-regulated gene expression in bacterial virulence and patho-
genesis of infection.
Figure 5. Expression of cytokine mRNA in lung tissue of mice
4 h after infection with PAO1 or PAO1DlasIRrhlIR. Lung tissue
from mice infected with 16106 CFU of either PAO1 (hatched bars) or
PAO1DlasIRrhlI (QSneg, open bars) was processed, total RNA extracted
and cDNA prepared. Expression of cytokine genes was assessed in RT-
qPCR using b-actin as the reference gene. All results are expressed as
gene expression relative to b-actin, and are presented as the mean 6
SD of five mice per group. A control group of lungs from mice that
underwent anaesthesia and intratracheal infusion of PBS without
bacteria was included (grey bars). Expression of all cytokines was
significantly higher in mice infected with bacteria than in sham-infected
mice (P,0.01, all groups, ANOVA) but there were no significant
differences between mice infected with PAO1 or PAO1DlasIRrhlIR
(QSneg).
doi:10.1371/journal.pone.0060973.g005
Figure 6. Anti-Pseudomonas antibody production by mice infected with PAO1 or PAO1DlasIRrhlIR. Mice were infected intratracheally with
16103 CFU of PAO1 or PAO1DlasIRrhlIR in an 0.5% agar slurry, and bled on day 22. Sera were tested in ELISA against antigen prepared from whole
killed PAO1, using isotype-specific detection antibodies for mouse IgM, IgG1, and IgG2a. Results are expressed as individual titers with a line
representing the median values. There were no significant differences (Mann–Whitney U test) between mice infected with PAO1 or PAO1DlasIRrhlIR
(QSneg).
doi:10.1371/journal.pone.0060973.g006
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